BaltCap, the private equity and venture capital investor in the Baltic States, is to invest in a leading Estonian dental care company Dental Invest Estonia (DIE).
BaltCap Private Equity Fund II, advised by BaltCap, has agreed to invest in DIE group through new equity issue acquiring a 56 per cent ownership stake. The management team and the key doctors will own 44 per cent of the shares.
DIE, along with its subsidiaries, is the leading dental healthcare provider in Estonia. Having over 17 years of experience the Group has been the innovation leader in Estonia by adopting modern technologies and introducing new services to the market. Orthodontics (prevention and correction of irregular teeth), restorative dentistry and children’s dentistry have traditionally been the Group’s core services. Recently DIE has expanded activities now covering also regular dentistry, ENT (ear, nose, throat) disorder treatment, speech therapy, physiotherapy, sleep disorder treatment and oral and maxillofacial surgery. The Group has adopted myo-functional treatment as a teamwork approach that has been highly recognised by medical experts globally. The Group is additionally active in offering dental laboratory services and exporting dental care equipment.
“We believe that healthcare industry has excellent long term perspectives with dental care being one of the fastest growing segments. DIE group has a strong team of professionals and we are impressed with the state-of-the-art chain of clinics they have built. With our investment, BaltCap wants to help the group to develop into a true regional leader in dental and dental related healthcare,” comments Martin Kõdar, Managing Partner of BaltCap.
“We were looking for a long term investor for the group to enable us carry out our expansion plans. We selected BaltCap for their professional approach, dedication and understanding of our business needs. Having BaltCap as a long term partner gives us confidence to expand our service offering and clinics network,” says Vallo Veering, Founder of DIE.
The transaction is planned to be completed in December 2015 and is subject to the approval of the Estonian Competition Authority. The parties have agreed not to disclose the transaction price.
